NCT02321436 - Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions

StrokeUpper Limb Spasticity

Interventions

BIOLOGICAL

Botulinum toxin type A

Subjects to receive Dysport® 500U administered intramuscularly in the targeted upper limb.

DRUG

Placebo

Placebo administered intramuscularly in the targeted upper limb.

Trial Locations (4)

Center for Neurodiagnostic and Therapeutic Services Metropolitan Medical Center, Manila

Department of rehabilitation Medicine Faculty of medicine Siriraj Hospital, Madihol University Hospital, Bangkok

Neurology Laboratory -University Malaya Medical Centre, Kuala Lumpur

TTSH Rehabilitation Centre Ang Mo Kio Community Hospital, Singapore